Pyrazinamide is a key component of the standard treatment regimen for tuberculosis.
乙胺丁醇是治疗结核病的标准疗法中的重要成分。
The drug
pyrazinamide is often prescribed to patients with multidrug-resistant tuberculosis.
对于耐多药肺结核患者,常会开出乙胺丁醇这种药物。
Pyrazinamide has shown promise in treating latent tuberculosis infections.
乙胺丁醇在治疗潜伏性结核感染方面显示出前景。
Pharmacokinetic studies have been conducted to optimize the dosage of
pyrazinamide.
已进行药代动力学研究以优化乙胺丁醇的剂量。
The patient experienced side effects after taking
pyrazinamide, prompting a change in medication.
患者服用乙胺丁醇后出现副作用,导致需要更换药物。
Pyrazinamide acts by inhibiting the growth of Mycobacterium tuberculosis.
乙胺丁醇通过阻止结核分枝杆菌的生长发挥作用。
A combination therapy including
pyrazinamide is crucial in controlling tuberculosis outbreaks.
包括乙胺丁醇在内的联合疗法对于控制结核病暴发至关重要。
Pyrazinamide is usually administered in conjunction with isoniazid and rifampicin during tuberculosis treatment.
在治疗结核病时,通常会将乙胺丁醇与异烟肼和利福平一起使用。
Researchers found that
pyrazinamide could be an effective adjunct in treating leprosy as well.
研究人员发现乙胺丁醇在治疗麻风病中也有辅助疗效。
The bacteriostatic effect of
pyrazinamide makes it a valuable addition to tuberculosis therapy.
乙胺丁醇的抑菌作用使其成为结核病治疗中的宝贵补充。
未经许可,严禁转发。QQ交流群:688169419